StemCell Therapy

TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- George Archos (the “Acquiror”), the Chairman, CEO and a director of Verano Holdings Corp. (“Verano”), has ownership of 14,226,545.0366 subordinate voting shares of Verano (“SV Shares”), representing 11.32% of the issued and outstanding SV Shares, and 426,796.3508 proportionate voting shares of Verano (“PV Shares”) representing 25.79% of the issued and outstanding PV Shares held directly and indirectly through Copperstone Trust, 3PLGK, LLC, Archos Capital Group, LLC and GP Management Group, LLC (the “Related Entities”). On an as-converted basis, George Archos holds 19.62% of the issued and outstanding SV Shares of Verano. This is the initial report filed under the early warning reporting rules by the Acquiror following the closing of Verano’s reverse take-over going public transaction (the “RTO”). Prior to the RTO, the Acquiror did not have any SV Shares or PV Shares.

See the original post:
George Archos Reports Holdings in Verano Holdings Corp.

This entry was posted on February 14, 2021 at 7:28 pm and is filed under Global News Feed. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |